Continued Innovation to Improve Diabetes Care
No one should have to make trade-offs when it comes to health. For 100 years, we’ve been focused on addressing the impact of diabetes and improving the lives of people managing the disease. In our recent history, we’ve introduced options that are widely used and have helped with insulin health care costs:
In 2016, we launched the first follow-on biologic insulin in the U.S.
In 2019, we introduced our non-branded version of our most popular insulin at a list price 50% lower than its branded counterpart and then lowered the price by an additional 40% in 2022
In 2020, we created the Lilly Insulin Value Program, enabling the uninsured and commercially insured access to $35 Lilly insulin
In 2021, we committed all our insulins to the Medicare Part D Savings Model, expanding $35 access even further
But our work to find better ways to support people living with diabetes goes beyond insulin pricing. We’re constantly in search of the next scientific breakthrough—the innovation that will uncover new and better treatments or even, one day, eliminate this disease.
The History of Diabetes Research
Our work to find better treatments is far from over, but we've come a long way. See the important milestones that got us here.
Our Portfolio of Current Medicines
We're constantly working to advance the next great breakthrough. Take a look at all our current medicines, including those for diabetes.